COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

30,211 Articles (22,215 medRxiv, 7,996 bioRxiv)

Most recent first Previous |  Page 395: Articles 3941-3950  | Next

COVID-19 diagnostic testing underestimated cases amongst females in Pakistan
Ghanchi, N. K., Masood, K. I., Nasir, A., Islam, N., Ansar, Z., Hasan, Z.
10.1101/2023.01.30.23285225 — Posted: 2023-02-01
Metaproteomic analysis of nasopharyngeal swab samples to identify microbial peptides and potential co-infection status in COVID-19 patients
Bihani, S., Gupta, A., Mehta, S., Rajczewski, A., Johnson, J., Borishetty, D., Griffin, T. J., Srivastava, S., Jagtap, P.
10.1101/2023.01.31.525328 — Posted: 2023-02-01
Mucociliary Clearance Augmenting Drugs Block SARS-Cov-2 Replication in Human Airway Epithelial Cells
Campos-Gomez, J., Fernandez Petty, C., Mazur, M., Tang, L., Solomon, G. M., Joseph, R., Li, Q., Peabody Lever, J. E., Hussain, S. S., Harrod, K. S., Onuoha, E., Kim, H., Rowe, S. M.
10.1101/2023.01.30.526308 — Posted: 2023-02-01
Structural prediction of chimeric immunogens to elicit targeted antibodies against betacoronaviruses
Simpson, J., Kasson, P. M.
10.1101/2023.01.31.526494 — Posted: 2023-02-01
Scalable neighbour search and alignment with uvaia
de Oliveira Martins, L., Mather, A. E., Page, A. J.
10.1101/2023.01.31.526458 — Posted: 2023-01-31
Current Status and Emerging Trends of COVID-19-related Studies in Seven ''Tropical Medicine''-entitled Journals
Zhang, X., Zhong, Z., Luo, P., Zhu, C., Huang, Y., Wu, C., Pan, X., Huang, Z.
10.1101/2023.01.30.23285173 — Posted: 2023-01-31
Coinfection with Strongyloides and SARS-CoV-2: protocol for a systematic review
Rosca, E. C., Heneghan, C., Spencer, E. A., Pluddemann, A., Maltoni, S., Gandini, S., ONAKPOYA, I., Evans, D., Conly, J. M., Jefferson, T.
10.1101/2023.01.30.23285219 — Posted: 2023-01-31
Single-cell multi-omic topic embedding reveals cell-type-specific and COVID-19 severity-related immune signatures
Zhou, M., Zhang, H., Bai, Z., Mann-Krzisnik, D., Wang, F., Li, Y.
10.1101/2023.01.31.526312 — Posted: 2023-01-31
A comprehensive survey of coronaviral main protease active site diversity in 3D: Identifying and analyzing drug discovery targets in search of broad specificity inhibitors for the next coronavirus pandemic
Lubin, J. H., Martinusen, S. G., Zardecki, C., Olivas, C., Bacorn, M., Balogun, M., Slaton, E. W., Wu, A. W., Sakeer, S., Hudson, B. P., Denard, C., Burley, S. K., Khare, S. D.
10.1101/2023.01.30.526101 — Posted: 2023-01-31
Fitness effects of mutations to SARS-CoV-2 proteins
Bloom, J. D., Neher, R. A.
10.1101/2023.01.30.526314 — Posted: 2023-01-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).